Please login to the form below

Not currently logged in
Email:
Password:

COVID-19 and coronavirus

EMA accepts Valneva’s marketing authorisation application for COVID-19 vaccine

EMA accepts Valneva’s marketing authorisation application for COVID-19 vaccine

The European Medicines Agency (EMA) has accepted Valneva’s marketing authorisation application (MAA) for its COVID-19 vaccine candidate, VLA2001. ... Valneva’s vaccine candidate is currently the only whole virus, inactivated, adjuvanted candidate for

Latest news

More from news
Approximately 0 fully matching, plus 541 partially matching documents found.

Latest Intelligence

  • The pandemic preparedness paradox The pandemic preparedness paradox

    We must act now. It would be easier to start this work after COVID-19, after we all have our feet under us once again. ... control of COVID-19, the next emergency will draw all attention and sap the collective will.

  • The search for effective drug treatments for COVID-19 The search for effective drug treatments for COVID-19

    a 10-day dosing regimen of remdesivir administered intravenously versus standard of care in patients with moderate manifestations of COVID-19. ... The European Commission has signed a joint procurement agreement for Gilead’s COVID-19 antiviral

  • How will COVID-19 affect uptake of vaccinations against other diseases? How will COVID-19 affect uptake of vaccinations against other diseases?

    Will COVID-19 help or hinder the quest to increase uptake of other vaccinations? ... Not just for the COVID-19 programmes, but for every other vaccine made these days.

  • The impact of COVID-19 on clinical trials The impact of COVID-19 on clinical trials

    The novel coronavirus (COVID-19) pandemic has created an unprecedented global health crisis and all industry sectors are working to assess both the impact and the optimal path forward. ... Clinical trials with the following characteristics are especially

  • COVID-19 hits supply chains COVID-19 hits supply chains

    Too much, way too much, cried our leaders, as the coronavirus (COVID-19) pandemic shuttered factories in the Hubei province. ... Reaction to the coronavirus crisis sheds light on fundamental shifts occurring in the US political landscape, according to

More from intelligence
Approximately 0 fully matching, plus 7 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 13 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Jet Off with Maloff Protect

Latest intelligence

Why big pharma needs to be braver
The last few years have seen the pharmaceutical industry undergo a rapid metamorphosis in the face of unprecedented change, but communications are one area that still needs an injection of...
Leveraging Real-World Evidence for Cell and Gene Therapies
Regulators and reimbursement bodies are increasingly turning to real-world evidence (RWE) to understand the long-term value of drugs, in particular novel therapies. Here, Mariam Bibi, Senior Director, Global RWE at...
Food Allergy – Is avoidance the only option?
Following on from Allergy Awareness Week 2022, we’re continuing the discussion about food allergies and the experiences of those who live with them. In this blog, we discuss the current...